Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Monofer in iron-deficient non-anaemic chronic kidney disease
2014-004133-16Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Feb 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) and iron deficiency anemia (IDA) comparing Monofer with Placebo (2 arms). Primary endpoints: Change in physical function and Change in quality of life. Started Feb 2015; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
chronic kidney disease (CKD)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2014-004133-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004133-16.